Given the accumulation of reports showing MCT1 expression in various cancer cells (e.g. breast, colon, and lung cancer) and its correlation with poor prognosis [2,3,5,20,21], these previous reports indicate that MCT1 should play an important role for the survival of myeloma cells. Here, SLC16A1 is linked to cancer.